Type 1 Diabetes Has Early Adverse Effects on Bone Mineral Density
For children with type 1 diabetes, adverse effects on bone mineral density begin early in the course of disease.
Osteoporosis
Fact or Myth: Does Drinking Too Much Milk Increase the Risk for Osteoporosis?
When it comes to bone health, is there such a thing as drinking too much milk?
Replacing Sedentary Time With Light Physical Activity Reduces Osteoporosis Risk
Substituting 30 minutes of sedentary time with light physical activity may improve bone mineral density and reduce the risk for osteoporosis in postmenopausal women.
Vitamin D Supplementation Linked to Lower Bone Turnover Markers
Patients with low vitamin D levels who take vitamin D supplements might experience suppressed bone turnover, potentially from parathyroid hormone reduction.
Research Needed to Improve Osteoporotic Drug Therapy: Takeaways From NIH Pathways to Prevention Workshop
Experts at the NIH’s Pathways to Prevention Workshop identified areas of research needed to advance long-term osteoporotic drug therapy.
Oral Bisphosphonates Linked to 6-Fold Increase in Risk for Osteonecrosis of the Jaw
The use of oral bisphosphonates is associated with a 6-fold increased risk for hospital admission with osteonecrosis of the jaw in postmenopausal women.
Low Rates of Osteoporosis Screening in Patients With Recent Stroke Despite High Fracture Risk
Rates of osteoporosis screening and treatment are low in patients with recent stroke despite elevated risk for low-trauma fracture.
Abaloparatide Followed by Alendronate Shows Promising Results for Women With Osteoporosis, T2D
Abaloparatide followed by alendronate treatment may improve bone mineral density in women with postmenopausal osteoporosis and type 2 diabetes.
Type 2 Diabetes Associated With Short-Term Risk for Fracture
Type 2 diabetes is associated with increased risk for fractures in the short term but not in the long term.
Risks, Benefits of Long-Term Drug Therapy for Osteoporosis Reviewed
Long-term osteoporosis drug therapy (ODT) reduces fracture risk in women but may increase risk for rare adverse events, and research gaps surround use of long-term drug therapies for osteoporotic fracture prevention.
Next post in Osteoporosis
